Astrea Bioseparations
Andrew Kellett serves as the Chief Financial Officer at Biotage since September 2023, overseeing financial operations for a public company specializing in separations technology. Concurrently, Kellett holds the CFO position at Astrea Bioseparations Ltd, a biotechnology company focused on chromatography solutions, since April 2022. Kellett has extensive experience in financial leadership roles, including previous positions as CFO at Technetix, Cmed Group, and Finance Director at Genetix and Quest Diagnostics. Notable achievements include successful acquisitions, business transformations, and significant fundraising efforts across multiple organizations. Kellett holds a degree in Economics from Aberystwyth University.
This person is not in any offices
Astrea Bioseparations
1 followers
Since 1987, Astrea Bioseparations has been pioneering the design, development and manufacture of affinity purification technology for lab-scale and industrial-scale bioprocessing. With over 25 years experience and success in the development of affinity products and design of new custom adsorbents, Astrea is a world leader in its field. Astrea Bioseparations has sales and support offices in North America and Europe, R&D facilities in Cambridge, UK and manufacturing facilities located on the Isle of Man, British Isles and Joliette, QC, Canada ensuring that we are able to meet your needs and support your application wherever you are. OUR EXPERTISE: • Extensive range of bioseparation products • Custom designed chromatography adsorbents • Over 25 years experience & success • Cost effective solutions • Proven Mimetic Ligand™ technology • Dedicated professional service • Full technical support & in-house training • Experts in adsorbent development & downstream process optimization • Established manufacturing facility (ISO 9001)